Search research articles
Contact Us
Filters
Showing results (51-60 of 395) with videos related to
Page
of 40
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
August 9, 2012
[Prednisone for rheumatoid arthritis: the detriment of the doubt]
Maarten Boers
Annals of the Rheumatic Diseases
|
February 26, 2015
Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?
Maarten Boers
Rheumatology (Oxford, England)
|
June 20, 2023
Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
Maarten Boers
The Journal of Rheumatology
|
October 16, 2020
Long-term Glucocorticoid Use in Rheumatoid Arthritis
Maarten Boers, Theodore Pincus
Rheumatology (Oxford, England)
|
April 16, 2013
A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis
Maarten Boers, Frank Buttgereit
Arthritis and Rheumatism
|
August 20, 2010
Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials
Maarten Boers, Piet J Kostense
Lancet (London, England)
|
October 31, 2013
Biological treatment in rheumatoid arthritis: when to stop?
John R Kirwan, Maarten Boers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 5, 2024
Why are local epidural glucocorticoid injections associated with fractures? Drug, disease, or both?
Willem F Lems, Maarten Boers
The Journal of Rheumatology
|
May 8, 2003
Can progression of radiographic joint damage be predicted early in rheumatoid arthritis?
Alexandre E Voskuyl, Maarten Boers
Rheumatology Advances in Practice
|
May 9, 2022
<b>Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional</b> <b>study</b>
Marwan Bukhari, Nicola Goodson, Maarten Boers
Page
of 40
Search research articles
Search
Showing results (51-60 of 395) with videos related to
Sort By:
Page
of 40
Nederlands Tijdschrift Voor Geneeskunde
|
August 9, 2012
[Prednisone for rheumatoid arthritis: the detriment of the doubt]
Maarten Boers
Annals of the Rheumatic Diseases
|
February 26, 2015
Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?
Maarten Boers
Rheumatology (Oxford, England)
|
June 20, 2023
Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider
Maarten Boers
The Journal of Rheumatology
|
October 16, 2020
Long-term Glucocorticoid Use in Rheumatoid Arthritis
Maarten Boers, Theodore Pincus
Rheumatology (Oxford, England)
|
April 16, 2013
A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis
Maarten Boers, Frank Buttgereit
Arthritis and Rheumatism
|
August 20, 2010
Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials
Maarten Boers, Piet J Kostense
Lancet (London, England)
|
October 31, 2013
Biological treatment in rheumatoid arthritis: when to stop?
John R Kirwan, Maarten Boers
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 5, 2024
Why are local epidural glucocorticoid injections associated with fractures? Drug, disease, or both?
Willem F Lems, Maarten Boers
The Journal of Rheumatology
|
May 8, 2003
Can progression of radiographic joint damage be predicted early in rheumatoid arthritis?
Alexandre E Voskuyl, Maarten Boers
Rheumatology Advances in Practice
|
May 9, 2022
<b>Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional</b> <b>study</b>
Marwan Bukhari, Nicola Goodson, Maarten Boers
Page
of 40